Sorafenib Plus S-1 in Advanced Solid Tumors

NCT01128998 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Sorafenib
DRUG: S-1

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]